BSEAGM/EGM2d ago · 18 Aug 2026, 03:48 pm
Please find attched postal ballot notice
Mankind Pharma Ltd · 543904
✦ AI SummaryMgmt Change
Mankind Pharma Ltd has announced a postal ballot notice for the appointment of Mr. Anish Vanraj Bafna as a Non-Executive Independent Director of the Company. The appointment is proposed for approval by the members of Mankind Pharma Ltd through remote e-voting.
Analysis Scores
Earnings Impact1/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Mankind Pharma Ltd - 543904 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Attachments (1)
📄pdf
Download →
efba1b50-1b04-4e00-a9f7-a430f9a2ada2.pdf
View document text
August 18, 2026
BSE Limited National Stock Exchange of India Limited
P J Towers, Exchange Plaza, C-1, Block G,
Dalal Street, Bandra Kurla Complex,
Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 543904 Symbol: MANKIND
Dear Sir/ Madam,
Subject: Postal Ballot Notice
Ref.: Regulation 30 & 51 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 (“Listing
Regulations”)
With reference to the captioned subject, please find enclosed herewith the Postal Ballot Notice
(“Notice”) dated August 10, 2026, for seeking approval of the Members by way of Special
Resolution through postal ballot via remote e-voting (“e-voting”) for appointment of Mr. Anish
Vanraj Bafna (DIN: 02925792) as a Non-Executive Independent Director of the Company.
In accordance with the applicable provisions of General Circular No. 14/2020 dated April 8,
2020 and General Circular No. 17/2020 dated April 13, 2020, read with other relevant circulars,
including General Circular No. 03/2025 dated September 22, 2025, issued by the Ministry of
Corporate Affairs, and the various circulars issued by the Securities and Exchange Board of
India in this regard, the aforesaid Notice has been dispatched electronically on Tuesday, August
18, 2026, to the Members whose names appear in the Register of Members of the Company
and/or in the Register of Beneficial Owners maintained by the Depositories as on Friday,
August 14, 2026 (“Cut-off Date”) and whose e-mail addresses are registered with the
Company/Depositories. The communication of assent or dissent by the Members in respect of
the Special Resolution proposed in the Notice shall take place only through the remote e-voting
system.
The Company has appointed National Securities Depository Limited (“NSDL”) for facilitating
e-voting to enable the members to cast their votes electronically. Details pertaining to e-voting
are as follows:
Cut-off Date Friday, August 14, 2026
Commencement of e-voting period Wednesday, August 19, 2026 (9:00 AM IST)
End of e-voting period Thursday, September 17, 2026 (5:00 PM IST)
(both days inclusive)
Declaration of results of e-voting On or before Monday, September 21, 2026
Please note that, the Notice is also available at the website of the Company i.e.
www.mankindpharma.com and at the website of website of NSDL at www.evoting.nsdl.com.
Further, upon declaration, the voting results along with the Scrutinizer’s Report shall be
uploaded on the website of the Company at www.mankindpharma.com and on the website of
NSDL at www.evoting.nsdl.com, and shall also be communicated to and uploaded on the
websites of BSE Limited at www.bseindia.com and National Stock Exchange of India Limited
at www.nseindia.com.
This is for your information and necessary dissemination.
Thanking You,
Yours Faithfully,
For Mankind Pharma Limited
Hitesh Kumar Jain
Company Secretary &
Compliance Officer
Encl.: A/a
MANKIND PHARMA LIMITED
Registered Office: 208, Okhla Industrial Estate, Phase III, New Delhi 110020, Delhi, India.
Telephone No. +91 11 47476600
Corporate Office: 262, Okhla Industrial Estate, Phase III, New Delhi 110020, Delhi, India.
Telephone No. +91 11 46846700
CIN: L74899DL1991PLC044843
Website: www.mankindpharma.com | Email: investors@mankindpharma.com
NOTICE OF POSTAL BALLOT
S. No. Index Section Page No.
1. Notice of Postal Ballot/E-voting 01
2. Notes to the Notice & E-voting Procedure 02-06
3. Explanatory Statement 07-08
4. Brief Profile 09
PROPOSAL
S. No. Proposed Resolution Type of Resolution
1. Appointment of Mr. Anish Vanraj Bafna (DIN: 02925792) as a Non- Special Resolution
Executive Independent Director
Postal Ballot / E-voting Timeline:
Cut-off Date for Voting Opens Voting Closes Result
E-voting
Friday, August Wednesday, August 19, 2026 Thursday, September 17, 2026 On or before Monday,
14, 2026 (9:00 AM IST) (5:00 PM IST) (both days inclusive) September 21, 2026
The Notice of the Postal Ballot/E-voting and Explanatory Statement is prepared pursuant to the applicable provisions
of the Companies Act, 2013 (“Act”) and Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“Listing Regulations”), as amended from time to time.
Back to Index
01-09
NOTICE OF POSTAL BALLOT
[Pursuant to Section 110 and Section 108 of the Companies Act, 2013, read with Rule 20 and 22 of the
Companies (Management and Administration) Rules, 2014]
Dear Member(s), designated as a Non-Executive Independent Director
of the Company with effect from August 10, 2026,
Notice is hereby given that the resolution set out below
pursuant to the provisions of Section 161 of the Act
is proposed for approval by the members of Mankind
read with Articles of Association of the Company and
Pharma Limited (“the Company”) by means of Postal
based upon the recommendation of the Nomination
Ballot, only by remote e-voting process (“e-voting”)
and Remuneration Committee and who has consented
being provided by the Company to all its members to
to act as a Director of the Company and who meets the
cast their votes electronically, pursuant to Section 110
criteria for independence as provided under Section
of the Act, Rule 22 of the Companies (Management
149(6) of the Act and Regulation 16(1)(b) of the Listing
and Administration) Rules, 2014 (“the Rules”) and
Regulations, and has submitted a declaration to that
other applicable provisions of the Act and the Rules,
effect, be and is hereby appointed as a Non-Executive
General Circular Nos. 14/2020 dated April 8, 2020 and
Independent Director of the Company, not liable to retire
17/2020 dated April 13, 2020 read with other relevant
by rotation, for a term of five (5) consecutive years
circulars, including General Circular No. 03/2025
commencing from August 10, 2026.
dated September 22, 2025, issued by the Ministry of
Corporate Affairs (“MCA Circulars”), Regulation 44 of RESOLVED FURTHER THAT Mr. Anish Vanraj Bafna
the Listing Regulations, Secretarial Standard on General shall be entitled to receive the sitting fees for attending
Meetings (“SS-2”) issued by the Institute of Company meetings of the Board or its Committees, or such other
Secretaries of India and other applicable laws, rules and meetings, at a rate, as may be decided by the Board
regulations (including any statutory modification(s) or from time to time, reimbursement of expenses incurred
re-enactment(s) thereof for the time being in force). for participating in the Board and other meetings and
profit-related commission as may be decided by the
The Statement, pursuant to the provisions of Section Board from time to time, subject to the limits and
102(1) and other applicable provisions of the Act read provisions prescribed under Sections 197, 198 and any
with the Rules, setting out all material facts relating to other applicable provisions of the Act and the rules
the resolution proposed in this Postal Ballot Notice and made thereunder and applicable provisions of the
additional information as required under the Listing Listing Regulations, each as may be amended from
Regulations and circulars issued thereunder is attached. time to time.
RESOLVED FURTHER THAT the Board of Directors of
SPECIAL BUSINESS:
the Company or any person(s) authorised by the Board
be and is hereby authorised to do all such acts, deeds,
Item No. 1: Appointment of Mr. Anish Vanraj Bafna
matters and things, and to execute all such documents,
(DIN: 02925792) as a Non-Executive Independent
writings and instruments, as may be necessary,
Director
expedient or desirable for the purpose of giving effect
To consider and, if thought fit, to pass the following to this resolution and to settle any question, difficulty or
resolution as a Special Resolution: doubt that may arise in this regard.”
“RESOLVED THAT pursuant to the provisions of
Sections 149, 150, 152 and other applicable provisions, By Order of the Board of Directors
if any, read with Schedule IV of the Companies Act, For Mankind Pharma Lim
[Showing first 8,000 characters — download PDF for full document]